| Product Code: ETC10319974 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Grenada experienced a shift in the concentration of spinal devices and biologics import shipments, moving from high concentration in 2023 to a more moderate level. The top exporting countries to Grenada include Saint Lucia, Barbados, Ireland, USA, and Trinidad and Tobago. Despite a negative Compound Annual Growth Rate (CAGR) of -3.58% from 2020 to 2024, there was a positive growth rate of 3.24% from 2023 to 2024. This indicates a potential rebound in the market and a diversification of import sources, offering opportunities for market expansion and resilience in Grenada`s healthcare sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Spinal Devices and Biologics Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Spinal Devices and Biologics Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Spinal Devices and Biologics Market - Industry Life Cycle |
3.4 Grenada Spinal Devices and Biologics Market - Porter's Five Forces |
3.5 Grenada Spinal Devices and Biologics Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.6 Grenada Spinal Devices and Biologics Market Revenues & Volume Share, By Biologics Type, 2021 & 2031F |
3.7 Grenada Spinal Devices and Biologics Market Revenues & Volume Share, By Surgery Type, 2021 & 2031F |
3.8 Grenada Spinal Devices and Biologics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Grenada Spinal Devices and Biologics Market Revenues & Volume Share, By Product Form, 2021 & 2031F |
4 Grenada Spinal Devices and Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Spinal Devices and Biologics Market Trends |
6 Grenada Spinal Devices and Biologics Market, By Types |
6.1 Grenada Spinal Devices and Biologics Market, By Device Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Device Type, 2021 - 2031F |
6.1.3 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Spinal Implants, 2021 - 2031F |
6.1.4 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Spinal Biologics, 2021 - 2031F |
6.1.5 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Spinal Rods, 2021 - 2031F |
6.1.6 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Spinal Cages, 2021 - 2031F |
6.2 Grenada Spinal Devices and Biologics Market, By Biologics Type |
6.2.1 Overview and Analysis |
6.2.2 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Bone Grafts, 2021 - 2031F |
6.2.3 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Stem Cell Therapy, 2021 - 2031F |
6.2.4 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Platelet Rich Plasma, 2021 - 2031F |
6.2.5 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Growth Factors, 2021 - 2031F |
6.3 Grenada Spinal Devices and Biologics Market, By Surgery Type |
6.3.1 Overview and Analysis |
6.3.2 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Fusion Surgery, 2021 - 2031F |
6.3.3 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Minimally Invasive, 2021 - 2031F |
6.3.4 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Reconstructive Surgery, 2021 - 2031F |
6.3.5 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Fusion Procedures, 2021 - 2031F |
6.4 Grenada Spinal Devices and Biologics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.4.5 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Rehabilitation Centers, 2021 - 2031F |
6.5 Grenada Spinal Devices and Biologics Market, By Product Form |
6.5.1 Overview and Analysis |
6.5.2 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.5.3 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Biocompatible Materials, 2021 - 2031F |
6.5.4 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Membranes, 2021 - 2031F |
6.5.5 Grenada Spinal Devices and Biologics Market Revenues & Volume, By Gels, 2021 - 2031F |
7 Grenada Spinal Devices and Biologics Market Import-Export Trade Statistics |
7.1 Grenada Spinal Devices and Biologics Market Export to Major Countries |
7.2 Grenada Spinal Devices and Biologics Market Imports from Major Countries |
8 Grenada Spinal Devices and Biologics Market Key Performance Indicators |
9 Grenada Spinal Devices and Biologics Market - Opportunity Assessment |
9.1 Grenada Spinal Devices and Biologics Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.2 Grenada Spinal Devices and Biologics Market Opportunity Assessment, By Biologics Type, 2021 & 2031F |
9.3 Grenada Spinal Devices and Biologics Market Opportunity Assessment, By Surgery Type, 2021 & 2031F |
9.4 Grenada Spinal Devices and Biologics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Grenada Spinal Devices and Biologics Market Opportunity Assessment, By Product Form, 2021 & 2031F |
10 Grenada Spinal Devices and Biologics Market - Competitive Landscape |
10.1 Grenada Spinal Devices and Biologics Market Revenue Share, By Companies, 2024 |
10.2 Grenada Spinal Devices and Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here